Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LoDoCo-TAVR: Colchicine for THV Thrombosis after TAVR
NCT07411768Recruiting
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Mar 2026
- Primary completion
- Jun 2028
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of colchicine in prosthetic valve thrombosis (PVT) (2 arms), sponsored by National Center for Cardiovascular Disease. Primary endpoint: Incidence of Transcatheter Heart Valve Thrombosis at 1 year. Started Mar 2026; status: recruiting.
02
Drugs
colchicine
03
Conditions
prosthetic valve thrombosis (PVT)
Beyond the preview
Go deeper on NCT07411768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07411768.